With the analysis among 2,669 patents, we discovered top 431 key players by total patent application. F. Hoffmann-La Roche Ltd., Novartis AG, Genentech, Inc. are dominant in this area. They take 8.62% of the total patent filing.
F. Hoffmann-La Roche Ltd.
Basel-Stadt, Switzerland
Patent: 77
California, United States
Patent: 74
Louisiana, United States
Patent: 60
Bayern, Germany
Patent: 44
New York, United States
Patent: 40
Teva Pharmaceutical Industries Ltd.
Yeda Research & Development Co. Ltd.
Vaud, Switzerland
Patent: 26
With the analysis among 127 patents, we discovered top 37 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, AMLo Biosciences Ltd., Edinburgh Molecular Imaging Ltd. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Edinburgh Molecular Imaging Ltd.
EDINBURGH, United Kingdom
Patent: 11
Massachusetts, United States
Patent: 8
Illinois, United States
Patent: 5
California, United States
Patent: 5
Rejuvenan Global Health, Inc.
New York, United States
Patent: 4
Abcombi Biosciences, Inc.
New York, United States
Patent: 4
California, United States
Patent: 3
California, United States
Patent: 3
With the analysis among related 1,119 patents applied in the last 5 years. We discover 440 most active companies in this area. The fast-growing Genentech, Inc., Amgen, Inc., Actelion Pharmaceuticals Ltd. take 5.81% of patent filing during this period.
California, United States
Patent: 28
California, United States
Patent: 19
Actelion Pharmaceuticals Ltd.
Basel-Landschaft, Switzerland
Patent: 18
Rheinland-Pfalz, Germany
Patent: 16
Vaud, Switzerland
Patent: 15
Amylyx Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 14
Brandenburg, Germany
Patent: 13
Board of Trustees of the Leland Stanford Junior University
California, United States
Patent: 12
F. Hoffmann-La Roche Ltd.
With the analysis among related 1,119 patents in last 5 years, we discover 303 new entrants. Amgen, Inc., Actelion Pharmaceuticals Ltd., Amylyx Pharmaceuticals, Inc. are the most active new entrants in this area.
California, United States
Patent: 19
Actelion Pharmaceuticals Ltd.
Basel-Landschaft, Switzerland
Patent: 18
Amylyx Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 14
TRON - Translationale Onkologie an der Universitätsmedizin der
Rheinland-Pfalz, Germany
Patent: 11
Edinburgh Molecular Imaging Ltd.
EDINBURGH, United Kingdom
Patent: 11
California, United States
Patent: 10
Victoria, Australia
Patent: 9
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 9
Massachusetts, United States
Patent: 8
With the analysis among 928 patents, we discovered top 164 universities and scientific research institutions by total patent application. Duke University, University of Rochester, Vilnius University are dominant in this area. They take 13.04% of the total patent filing.
North Carolina, United States
Patent: 18
New York, United States
Patent: 17
Vilniaus apskritis, Lithuania
Patent: 14
Fujian Sheng, China
Patent: 14
The Johns Hopkins University
Thomas Jefferson University
Pennsylvania, United States
Patent: 13
The Rockefeller University
New York, United States
Patent: 12
Consejo Superior de Investigaciones Científicas
Zhejiang Sheng, China
Patent: 9
National University of Singapore
Central Region, Singapore
Patent: 8